ABCG2 and cancer: The presented findings do not agree with the observations of Spring et al. (2015) [31] and described by Chu et al. (2020) [13], in which a surprising effect of PDI in cancer cells was observed; PDI-induced ROS production directly damaged selected proteins, concretely some of the ABC transporters, which can diminish multidrug resistance [13,31].